Skip to main content
Premium Trial:

Request an Annual Quote

Judith Sulzberger Dies

Judith Sulzberger, who helped found the genome center at Columbia University that bears her name, has died, reports The New York Times. She was 87. Sulzberger became a doctor, and worked in private practice and clinical research, to avoid the family business — her family owns The New York Times. In the early 1990s, she provided the funding to establish the genome center at Columbia that focuses on using "genetics to identify the risks of disease, improve human health, and extend life." Sulzberger headed up special projects at the center and chaired the advisory board. Her own research at the center looked into the genome of the mosquito that transmits malaria.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.